J&J warns over pump safety; Researchers say their bot beats Intuitive's;

@FierceMedDev: Special Report: Top 10 Med Tech Investments of Q2. Feature | Follow @FierceMedDev

@MarkHFierce: U.K. researchers believe that low levels of a specific protein can signify aggressive colorectal cancer. More | Follow @MarkHFierce

@DamianFierce: Fresh deals and booming sales have Illumina brightening its 2013 guidance. News | Follow @DamianFierce

> Johnson & Johnson's ($JNJ) Codman unit has issued a safety warning on its MedStream infusion pump, and the FDA has assigned its most serious label to the problem. Note

> Qiagen ($QGEN) and Exosome Diagnostics have teamed up to develop and sell sample preparation kits for nucleic acid analysis. News

> Tokyo Institute of Technology scientists have developed a surgical robot they say would cost between a third and a 10th of Intuitive Surgical's ($ISRG) da Vinci system, but their prototype is at least 5 years away from clinical use. Article

> Cancer Genetics ($CGIX) has launched a new cervical cancer test, designed to screen women with HPV-positive abnormal cervical lesions. More

> Co-Diagnostics and DNA Logix have formed a joint venture to develop infectious disease tests for the developing world. Story

> Life Technologies ($LIFE) has expanded its diagnostics platform offerings, launching two new PCR systems. Item

> Hologic ($HOLX) won FDA approval to pair its Aptima HPV assay with the fully automated Panther diagnostic system. Release

Biotech News

@FierceBiotech: PR: Verastem receives orphan drug designation from the FDA for defactinib in mesothelioma. Release | Follow @FierceBiotech

@RyanMFierce: Roche highlights more upbeat PhIII data for 'breakthrough' leukemia contender. News | Follow @RyanMFierce

@EmilyMFierce: Scientists advocate for more responsible preclinical studies. Item | Follow @EmilyMFierce

> Merck advances cardio drug under FDA review. More

> Big Pharma agrees to widen access to clinical trial data. Story

> After FDA meeting, Sarepta plans fast filing for DMD drug eteplirsen. Report

Pharma News

@FiercePharma: Lilly sales up 6%, to $5.93B; Cymbalta up 22% (!). Too bad it gets generic rivals later this year. Release | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Special report on the projected top 20 orphan drugs of 2018... see who made the list. Feature | Follow @CarlyHFierce

> GlaxoSmithKline sales tick up, but China probe will hit growth. Story

> GlaxoSmithKline CEO says HQ, British execs 'knew nothing' of China fraud. Report

Biomarkers News

> Epigenetic tags point to a new generation of age-related biomarkers. Report

> Nerves could predict aggressiveness of prostate cancer. More

> Takeda and Zinfandel advance Alzheimer's biomarker work. Story

> Plaque buildup trajectory may serve as a clue for Alzheimer's. Article

> Autism clues: UC Davis team spots two new potential biomarkers of the condition. Item

Drug Delivery News

 @MichaelGFierce: Regulus completes $49M public offering to support microRNA tech. Report | Follow @MichaelGFierce

> Novaliq secures CE mark for OTC drop to treat dry eye. News

> Supercomputer-designed hypertension drug mimics natural hormone response. Story

> Imprimis to begin osteoarthritis cream PhIII, snags transdermal wound treatment. More

> Cancer drug breaches blood-brain barrier using nanovesicles. Article

> Flowonix reports longest service life ever in 6-year Prometra trial. Item

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.